Travere Therapeutics, Inc. (TVTX) Current Reports & Earnings Releases
Upcoming
- 2026-10-29 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-04 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-07-09 | 8-K | Officer / Director Changes | SEC |
| 2026-06-16 | 8-K | Officer / Director Changes | SEC |
| 2026-06-02 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2026-05-21 | 8-K | Officer / Director Changes, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2026-05-11 | 8-K | Material Agreement, Direct Financial Obligation, Unregistered Sales, Other Events, Financial Statements & Exhibits | SEC |
| 2026-05-04 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-04-14 | 8-K | Other Events | SEC |
| 2026-02-19 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-01-13 | 8-K | Other Events | SEC |
| 2026-01-12 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-10-30 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-09-10 | 8-K | Other Events | SEC |
| 2025-08-06 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-05-16 | 8-K | Officer / Director Changes, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2025-05-15 | 8-K | Other Events | SEC |
| 2025-05-01 | 8-K | Acquisition or Disposition, Financial Statements & Exhibits | SEC |
| 2025-04-30 | 8-K | Other Events | SEC |
| 2025-03-17 | 8-K | Other Events | SEC |
| 2025-02-20 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-02-11 | 8-K | Other Events | SEC |
| 2025-01-13 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-11-08 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-10-31 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-09-26 | 8-K | Other Events | SEC |
| 2024-09-06 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-08-01 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-05-13 | 8-K | Officer / Director Changes, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2024-05-06 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-04-24 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-02-23 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-02-15 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-01-08 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.